B Cell Design
B Cell Design is a French biotechnology company that develops and produces patented human Fc monoclonal antibodies for IVD manufacturers as recombinant alternatives to disease-state plasma, serving as positive controls and calibrators in diagnostic immunoassays across infectious disease, autoimmunity, and allergy verticals.
- Company typePrivate
- Founded2007
- HeadquartersLimoges, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What B Cell Design does
B Cell Design is a privately-held French biotechnology company, founded in 2007 and headquartered in Illkirch-Graffenstaden, France. The company specializes in developing, producing, and distributing human Fc monoclonal antibodies (mAbs) for the in vitro diagnostic (IVD) industry, serving as a recombinant alternative to disease-state plasma for use as positive controls, calibrators, and quality control materials in immunoassays. Its core technology combines hybridoma methods with proprietary transgenic mouse platforms — InEps® (for IgM), Gamma®/GammaPrim® (for IgG), and Hamiga® (for IgA) — where the murine Ig heavy chain constant region is replaced by human Ig sequences, enabling production of fully human Fc chimeric antibodies with 98% purity and coefficient of variation below 5%. The portfolio spans over 70 catalog products across infectious diseases (e.g., Borrelia, CMV, Rubella, SARS-CoV-2), autoimmunity (e.g., SLA, Jo-1, rheumatoid factor), and allergies/food intolerances (e.g., Derf2, gliadin, tissue transglutaminase), complemented by custom antibody development services and analytical services (epitope mapping, paratope mapping, kinetics measurement).
The company operates a sales-led go-to-market motion targeting IVD manufacturers and diagnostic laboratories, distributing directly through its website and via a global network of distributors (Diarect/BBI Solutions, 2BScientific, Biokit, Operon, D-tek, Abcely, Aesku, Yarewell, among others). Pricing is quote-based and not publicly disclosed. Named enterprise customers include Werfen, BioVendor R&D, Virion-serion, and the ECAT Foundation, with multiple multi-year supply relationships. The company holds ISO 9001 certification and is compliant with IVDR and FDA 21 CFR Part 820 standards, positioning it to serve regulated diagnostic markets. Founded by Armelle Cuvillier (CSO) and Gaël Champier (CEO), with Michel Cogné (Académie des Sciences) as Scientific Advisor, the firm exhibits at industry events including MEDICA 2024 and pursues academic collaborations with Université de Tours and Université Jean Monnet to extend its platform.
B Cell Design firmographics
Firmographics- Name
- B Cell Design
- Legal name
- Bcell Design
- Website
- https://b-cell-design.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- B Cell Design is a French biotechnology company that develops and produces patented human Fc monoclonal antibodies for IVD manufacturers as recombinant alternatives to disease-state plasma, serving as positive controls and calibrators in diagnostic immunoassays across infectious disease, autoimmunity, and allergy verticals.
- Ownership category
- akta.pro rank
B Cell Design industry classification
Industry- Product category
- In Vitro Diagnostics Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
- akta.pro secondary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where B Cell Design is headquartered
LocationHeadquarters
- HQ city
- Limoges
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
B Cell Design business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Monoclonal Antibody Product Sales: B Cell Design develops, produces and distributes high-quality human Fc monoclonal antibodies for the diagnostic industry. Products are sold directly and through distributors for use as positive controls, calibrators, and quality control materials in IVD kits. Revenue is generated through product sales with pricing based on quote requests.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
B Cell Design product offering
Product offeringCore offering
B Cell Design develops, produces, and distributes human Fc monoclonal antibodies for the in vitro diagnostic (IVD) industry, generated through proprietary transgenic mouse platforms (InEps®, Gamma®/GammaPrim®, Hamiga®). The company offers a catalog of 70+ antibody clones targeting infectious disease, autoimmunity, and allergy biomarkers, alongside custom antibody development and analytical services including epitope mapping, paratope mapping, and kinetics measurement.
Product overview
B Cell Design is a biotechnology company that develops, produces, and distributes human Fc monoclonal antibodies (mAbs) for the in vitro diagnostic (IVD) industry. The product portfolio consists of over 70 monoclonal antibody products spanning three therapeutic areas: Infectious Diseases (IgM/IgA antibodies targeting pathogens including Borrelia, Chikungunya, CMV, Rubella, Toxoplasma, VZV, Mumps, Brucella, SARS-CoV-2 RBD, Zika, Dengue), Autoimmunity (IgG/IgM antibodies targeting autoimmune disease markers including SLA, PDCE2, LC1, Jo-1, KS, SP100, Rheumatoid Factor, TPO), and Allergies/Food Intolerances (IgE/IgA/IgG antibodies targeting allergens including Derf2, ovalbumin, beta-lactoglobulin, gliadin, tissue transglutaminase, and insulin). All products are produced using hybridoma technology with proprietary transgenic mouse platforms (InEps for IgM, Gamma/GammaPrim for IgG, Hamiga for IgA) and serve as alternatives to disease state plasma, functioning as positive controls and calibrators for IVD kits. The company also offers Custom Monoclonal Antibody Development Services for generating tailored human Fc mAbs and Analytical Services including epitope mapping, paratope mapping, and kinetics measurement.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom Monoclonal Antibody Development Services
Quantifiable outcome
- CV below 5% compared to ~20% for plasma-based materials
- +3 more outcomes
Companies that use B Cell Design
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
B Cell Design technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
B Cell Design partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- WerfencoreWerfen, an IVD manufacturer, partners with B Cell Design for stable and reliable sources of standard materials. Collaboration described as profitable and satisfactory for developing and manufacturing IVD products.
- BioVendor R&DcoreBioVendor R&D values cooperation with B Cell Design, utilizing the unique chimeric antibody production capability. Company appreciates excellent communication, high expertise, innovative ideas, and meeting deadlines.
- Diarect / BBI SolutionsminorListed as a partner/distributor in the B Cell Design partner ecosystem.
- Virion-serioncoreOver 5-year collaboration with Virion-serion. B Cell Design's patented technology and experience enabled joint development of excellent IgM antibodies for Virion-serion's product portfolio.
- ECAT FoundationcoreSince 2020, ECAT Foundation uses B Cell Design's human chimeric IgG anti-PF4/H (clone 1C12) for quality control samples in external quality assessment programme for HIT testing.
- Université de ToursminorAcademic partner listed in B Cell Design's partner ecosystem.
- Université Jean MonnetminorAcademic partner listed in B Cell Design's partner ecosystem.
- 2BScientificminorListed as a partner/distributor in the B Cell Design partner ecosystem.
- BiokitminorListed as a partner/distributor in the B Cell Design partner ecosystem.
- OperonminorListed as a partner/distributor in the B Cell Design partner ecosystem.
- D-tekminorListed as a partner/distributor in the B Cell Design partner ecosystem.
- AbcelyminorListed as a partner/distributor in the B Cell Design partner ecosystem.
- AeskuminorListed as a partner/distributor in the B Cell Design partner ecosystem.
- YarewellminorListed as a partner/distributor in the B Cell Design partner ecosystem.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
B Cell Design competitors and assessment
Company assessmentMarket position
Strengths5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
B Cell Design social profiles
Digital presenceB Cell Design compliance and trust
Trust signalCompliance3 records
B Cell Design financial estimates
Financial estimateRevenue estimate
Valuation estimate
B Cell Design leadership team
Management profileNumber of profiles
Profiles5 records
B Cell Design funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
B Cell Design M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about B Cell Design
What does B Cell Design do?
B Cell Design develops, produces, and distributes human Fc monoclonal antibodies for the in vitro diagnostic (IVD) industry, generated through proprietary transgenic mouse platforms (InEps®, Gamma®/GammaPrim®, Hamiga®). The company offers a catalog of 70+ antibody clones targeting infectious disease, autoimmunity, and allergy biomarkers, alongside custom antibody development and analytical services including epitope mapping, paratope mapping, and kinetics measurement.
Is B Cell Design a public or private company?
B Cell Design is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was B Cell Design founded?
B Cell Design was founded in 2007. It employs 11 to 50 people.
Where is B Cell Design based?
B Cell Design is headquartered in Limoges, France, in the Europe region.
How does B Cell Design make money?
One revenue line is on record: monoclonal Antibody Product Sales.
Does B Cell Design have an API?
No public API is recorded for B Cell Design.
What industry is B Cell Design in?
B Cell Design's product category is In Vitro Diagnostics Reagents. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.